Grandfield & Dodd’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$457K Buy
48,705
+60
+0.1% +$563 0.03% 141
2025
Q1
$346K Buy
48,645
+17,550
+56% +$125K 0.02% 159
2024
Q4
$363K Buy
31,095
+18,085
+139% +$211K 0.02% 162
2024
Q3
$267K Buy
+13,010
New +$267K 0.02% 189